{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T05:43:33Z","timestamp":1672379013572},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12640-022-00593-5","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T06:02:30Z","timestamp":1668232950000},"page":"1739-1757","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advanced Therapy and Clinical Trials to Treat Patients with Optic Nerve Diseases"],"prefix":"10.1007","volume":"40","author":[{"given":"Girish K.","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"L\u00f3pez-Paniagua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Crespo Millas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"issue":"4","key":"593_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1001\/archophthalmol.2011.1665","volume":"130","author":"F Abukhalil","year":"2012","unstructured":"Abukhalil F, Lam BL, Guy J (2012) Visual observations of an American patient with Leber hereditary optic neuropathy after purported injections of stem cells in China. Arch Ophthalmol 130(4):532\u2013534. https:\/\/doi.org\/10.1001\/archophthalmol.2011.1665","journal-title":"Arch Ophthalmol"},{"issue":"18","key":"593_CR2","doi-asserted-by":"publisher","first-page":"e1732","DOI":"10.1212\/WNL.0000000000008394","volume":"93","author":"RK Burt","year":"2019","unstructured":"Burt RK, Balabanov R, Han X et al (2019) Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica. Neurology 93(18):e1732\u2013e1741. https:\/\/doi.org\/10.1212\/WNL.0000000000008394","journal-title":"Neurology"},{"issue":"1","key":"593_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/pbc.22503","volume":"55","author":"GL Chantada","year":"2010","unstructured":"Chantada GL, Fandi\u00f1o AC, Guitter MR et al (2010) Results of a prospective study for the treatment of unilateral retinoblastoma. Pediatr Blood Cancer 55(1):60\u201366. https:\/\/doi.org\/10.1002\/pbc.22503","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"593_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/1352458517703802","volume":"24","author":"JA Cohen","year":"2018","unstructured":"Cohen JA, Imrey PB, Planchon SM et al (2018) Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis. Mult Scler 24(4):501\u2013511. https:\/\/doi.org\/10.1177\/1352458517703802","journal-title":"Mult Scler"},{"issue":"2","key":"593_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","volume":"11","author":"P Connick","year":"2012","unstructured":"Connick P, Kolappan M, Crawley C et al (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol 11(2):150\u2013156. https:\/\/doi.org\/10.1016\/S1474-4422(11)70305-2","journal-title":"Lancet Neurol"},{"issue":"1","key":"593_CR6","first-page":"81","volume":"2","author":"S Di Lauro","year":"2020","unstructured":"Di Lauro S, Garcia-Gutierrez MT, Fernandez-Bueno I (2020) Quantification of pigment epithelium-derived factor (PEDF) in an ex vivo coculture of retinal pigment epithelium cells and neuroretina. Allbiosolution 2(1):81","journal-title":"Allbiosolution"},{"key":"593_CR7","first-page":"243","volume":"22","author":"S Di Lauro","year":"2016","unstructured":"Di Lauro S, Rodriguez-Crespo D, Gayoso MJ et al (2016) A novel coculture model of porcine central neuroretina explants and retinal pigment epithelium cells. Mol Vis 22:243\u2013253","journal-title":"Mol Vis"},{"issue":"1","key":"593_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/pbc.22491","volume":"55","author":"IJ Dunkel","year":"2010","unstructured":"Dunkel IJ, Chan HSL, Jubran R et al (2010) High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma. Pediatr Blood Cancer 55(1):149\u2013152. https:\/\/doi.org\/10.1002\/pbc.22491","journal-title":"Pediatr Blood Cancer"},{"key":"593_CR9","doi-asserted-by":"publisher","unstructured":"Faber C, Heegaard S, Kiilgaard JF (2019) No Severe Adverse Effects from Intravitreally Injected Putative Adipose Tissue-Derived Stem Cells. Case Rep Ophthalmol Med. https:\/\/doi.org\/10.1155\/2019\/6927829","DOI":"10.1155\/2019\/6927829"},{"issue":"5","key":"593_CR10","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jaapos.2013.06.012","volume":"17","author":"C Fink","year":"2013","unstructured":"Fink C, Garcia-Filion P, Borchert M (2013) Failure of stem cell therapy to improve visual acuity in children with optic nerve hypoplasia. J AAPOS 17(5):490\u2013493. https:\/\/doi.org\/10.1016\/j.jaapos.2013.06.012","journal-title":"J AAPOS"},{"issue":"6","key":"593_CR11","doi-asserted-by":"publisher","first-page":"875","DOI":"10.4103\/1673-5374.184448","volume":"11","author":"M Foldvari","year":"2016","unstructured":"Foldvari M, Chen DW (2016) The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy. Neural Regen Res 11(6):875\u2013877. https:\/\/doi.org\/10.4103\/1673-5374.184448","journal-title":"Neural Regen Res"},{"issue":"2","key":"593_CR12","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3892\/mmr.2016.5367","volume":"14","author":"X Fu","year":"2016","unstructured":"Fu X, Tong Z, Li Q et al (2016) Induction of adipose-derived stem cells into Schwann-like cells and observation of Schwann-like cell proliferation. Mol Med Rep 14(2):1187\u20131193. https:\/\/doi.org\/10.3892\/mmr.2016.5367","journal-title":"Mol Med Rep"},{"issue":"7","key":"593_CR13","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00018-017-2691-x","volume":"75","author":"M Giannaccini","year":"2018","unstructured":"Giannaccini M, Usai A, Chiellini F et al (2018) Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress. Cell Mol Life Sci 75(7):1255\u20131267. https:\/\/doi.org\/10.1007\/s00018-017-2691-x","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"593_CR14","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.ophtha.2017.05.016","volume":"124","author":"J Guy","year":"2017","unstructured":"Guy J, Feuer WJ, Davis JL et al (2017) Gene therapy for Leber hereditary optic neuropathy: low- and medium-dose visual results. Ophthalmology 124(11):1621\u20131634. https:\/\/doi.org\/10.1016\/j.ophtha.2017.05.016","journal-title":"Ophthalmology"},{"issue":"2","key":"593_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1600-0420.2007.00987.x","volume":"86","author":"JB Jonas","year":"2008","unstructured":"Jonas JB, Witzens-Harig M, Arseniev L, Ho AD (2008) Intravitreal autologous bone marrow-derived mononuclear cell transplantation: a feasibility report. Acta Ophthalmol 86(2):225\u2013226. https:\/\/doi.org\/10.1111\/j.1600-0420.2007.00987.x","journal-title":"Acta Ophthalmol"},{"key":"593_CR16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0072-9752(08)93029-3","volume":"93","author":"C Lamirel","year":"2009","unstructured":"Lamirel C, Newman NJ, Biousse V (2009) Vascular neuro-ophthalmology. Handb Clin Neurol 93:595\u2013611. https:\/\/doi.org\/10.1016\/S0072-9752(08)93029-3","journal-title":"Handb Clin Neurol"},{"key":"593_CR17","doi-asserted-by":"publisher","unstructured":"Liu HL, Yuan JJ, Zhang Y et al (2020) Factors associated with rapid improvement in visual acuity in patients with Leber's hereditary optic neuropathy after gene therapy. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/aos.14379","DOI":"10.1111\/aos.14379"},{"issue":"2","key":"593_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.neuron.2012.10.002","volume":"76","author":"RH Masland","year":"2012","unstructured":"Masland RH (2012) The neuronal organization of the retina. Neuron 76(2):266\u2013280. https:\/\/doi.org\/10.1016\/j.neuron.2012.10.002","journal-title":"Neuron"},{"issue":"1","key":"593_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40135-019-00194-0","volume":"7","author":"LA Mesentier-Louro","year":"2019","unstructured":"Mesentier-Louro LA, Liao YJ (2019) Optic nerve regeneration: considerations on treatment of acute optic neuropathy and end-stage disease. Curr Ophthalmol Rep 7(1):11\u201320. https:\/\/doi.org\/10.1007\/s40135-019-00194-0","journal-title":"Curr Ophthalmol Rep"},{"issue":"12","key":"593_CR20","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1007\/s10792-019-01141-5","volume":"39","author":"A Oner","year":"2019","unstructured":"Oner A, Gonen ZB, Sevim DG, Sinim Kahraman N, Unlu M (2019) Six-month results of suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with optic atrophy: a phase 1\/2 study. Int Ophthalmol 39(12):2913\u20132922. https:\/\/doi.org\/10.1007\/s10792-019-01141-5","journal-title":"Int Ophthalmol"},{"issue":"10","key":"593_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-1041-8","volume":"9","author":"A Osborne","year":"2018","unstructured":"Osborne A, Khatib TZ, Songra L et al (2018) Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor\/tropomyosin-related kinase receptor-B signaling. Cell Death Dis 9(10):1\u201318. https:\/\/doi.org\/10.1038\/s41419-018-1041-8","journal-title":"Cell Death Dis"},{"issue":"1","key":"593_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/WNO.0b013e318199becf","volume":"29","author":"Y Oyama","year":"2009","unstructured":"Oyama Y, Burt RK, Thirkill C, Hanna E, Merrill K, Keltner J (2009) A case of autoimmune-related retinopathy and optic neuropathy syndrome treated by autologous nonmyeloablative hematopoietic stem cell transplantation. J Neuroophthalmol 29(1):43\u201349. https:\/\/doi.org\/10.1097\/WNO.0b013e318199becf","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"593_CR23","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4103\/mjdrdypu.mjdrdypu_260_18","volume":"12","author":"S Waduthantri","year":"2019","unstructured":"Waduthantri S (2019) Eye as a window to the brain in central nervous system diseases. Med J Dr DY Patil Vidyapeeth 12(4):376. https:\/\/doi.org\/10.4103\/mjdrdypu.mjdrdypu_260_18","journal-title":"Med J Dr DY Patil Vidyapeeth"},{"issue":"4884","key":"593_CR24","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1126\/science.3201231","volume":"242","author":"DC Wallace","year":"1988","unstructured":"Wallace DC, Singh G, Lott MT et al (1988) Mitochondrial DNA mutation associated with Leber\u2019s hereditary optic neuropathy. Science 242(4884):1427\u20131430. https:\/\/doi.org\/10.1126\/science.3201231","journal-title":"Science"},{"key":"593_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.21037\/sci.2018.04.02","volume":"5","author":"JN Weiss","year":"2018","unstructured":"Weiss JN, Levy S (2018) Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of retinitis pigmentosa. Stem Cell Investig 5:18. https:\/\/doi.org\/10.21037\/sci.2018.04.02","journal-title":"Stem Cell Investig"},{"key":"593_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.21037\/sci.2019.11.01","volume":"6","author":"JN Weiss","year":"2019","unstructured":"Weiss JN, Levy S (2019) Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow derived stem cells in the treatment of dominant optic atrophy. Stem Cell Investig 6:41. https:\/\/doi.org\/10.21037\/sci.2019.11.01","journal-title":"Stem Cell Investig"},{"key":"593_CR27","doi-asserted-by":"publisher","unstructured":"Weiss JN, Levy S (2020) Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of age-related macular degeneration. Medicines (Basel) 7(4). https:\/\/doi.org\/10.3390\/medicines7040016","DOI":"10.3390\/medicines7040016"},{"key":"593_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.21037\/sci.2017.11.05","volume":"4","author":"JN Weiss","year":"2017","unstructured":"Weiss JN, Levy S, Benes SC (2017) Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION). Stem Cell Investig 4:94. https:\/\/doi.org\/10.21037\/sci.2017.11.05","journal-title":"Stem Cell Investig"},{"issue":"10","key":"593_CR29","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.4103\/1673-5374.193251","volume":"11","author":"JN Weiss","year":"2016","unstructured":"Weiss JN, Levy S, Benes SC (2016) Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Leber\u2019s hereditary optic neuropathy. Neural Regen Res 11(10):1685\u20131694. https:\/\/doi.org\/10.4103\/1673-5374.193251","journal-title":"Neural Regen Res"},{"issue":"9","key":"593_CR30","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.4103\/1673-5374.165525","volume":"10","author":"JN Weiss","year":"2015","unstructured":"Weiss JN, Levy S, Benes SC (2015a) Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a case report of improvement in relapsing auto-immune optic neuropathy. Neural Regen Res 10(9):1507\u20131515. https:\/\/doi.org\/10.4103\/1673-5374.165525","journal-title":"Neural Regen Res"},{"issue":"6","key":"593_CR31","doi-asserted-by":"publisher","first-page":"982","DOI":"10.4103\/1673-5374.158365","volume":"10","author":"JN Weiss","year":"2015","unstructured":"Weiss JN, Levy S, Malkin A (2015b) Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a preliminary report. Neural Regen Res 10(6):982\u2013988. https:\/\/doi.org\/10.4103\/1673-5374.158365","journal-title":"Neural Regen Res"},{"issue":"3","key":"593_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00277-010-1071-5","volume":"90","author":"J Xu","year":"2011","unstructured":"Xu J, Ji BX, Su L et al (2011) Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population. Ann Hematol 90(3):343\u2013348. https:\/\/doi.org\/10.1007\/s00277-010-1071-5","journal-title":"Ann Hematol"},{"key":"593_CR33","doi-asserted-by":"publisher","unstructured":"Zubizarreta I, Fl\u00f3rez-Grau G, Vila G et al (2019) Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial. Proc Natl Acad Sci U S A. 116:8463\u20138470. https:\/\/doi.org\/10.1073\/pnas.1820039116","DOI":"10.1073\/pnas.1820039116"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-022-00593-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-022-00593-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-022-00593-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T04:38:48Z","timestamp":1672288728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-022-00593-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["593"],"URL":"https:\/\/doi.org\/10.1007\/s12640-022-00593-5","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}